All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Dulaglutide Trulicity: How It Works and What to Expect

If you are researching GLP-1 medications for type 2 diabetes, dulaglutide is a name you will come across often.

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

If you're researching GLP-1 medications for type 2 diabetes, dulaglutide is a name you'll come across often.

If you're researching GLP-1 medications for type 2 diabetes, dulaglutide is a name you'll come across often. This dulaglutide Trulicity guide covers everything you need to know (how it works, what to expect from dosing, the side effects, and how it stacks up against other options in the GLP-1 class.

Key Takeaways: - Learn how dulaglutide works - Dosing, Effectiveness, and What the Trials Show - Side Effects and Practical Considerations - Learn how dulaglutide compares to other glp-1 options

Dulaglutide has been on the market since 2014 under the brand name Trulicity. It's one of the most widely prescribed GLP-1 receptor agonists in the world, largely because of its ease of use and strong insurance coverage.

How dulaglutide (Trulicity) lowers blood sugar

Dulaglutide is a GLP-1 receptor agonist. It mimics a natural hormone called glucagon-like peptide-1, which your gut releases after eating. This hormone tells your pancreas to release insulin, signals your liver to reduce glucose output, and slows down digestion so food moves through your stomach more gradually.

The result is lower blood sugar levels throughout the day, with less risk of the dangerous lows (hypoglycemia) that some older diabetes medications can cause.

Dulaglutide is a once-weekly injection. It comes in a prefilled, single-use pen that doesn't require mixing or reconstitution calculator. You press it against your skin, click a button, and the injection happens automatically. Most people describe the needle as very small and the injection as nearly painless.

"Compounding pharmacies serve a critical role in healthcare, but patients need to understand the difference between a properly regulated 503B facility and an unregulated operation. Ask about PCAB accreditation and third-party testing.") Dr. Scott Brunner, PharmD, Alliance for Pharmacy Compounding

The convenience factor is a big reason dulaglutide remains popular. There's no refrigeration needed after the first use, no dose calculations, and no visible needle. For people who are nervous about injections, the device design helps ease that anxiety.

To understand how GLP-1 receptor agonists work more broadly, check out our , which covers the class mechanisms in detail.

Dosing, Effectiveness, and What the Trials Show

Dulaglutide is available in four doses: 0.75 mg, 1.5 mg, 3.0 mg, and 4.5 mg. Most people start at 0.75 mg weekly and increase to 1.5 mg after four weeks. The higher doses (3.0 mg and 4.5 mg) were approved later for additional blood sugar and weight benefit.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Dulaglutide Trulicity: hands holding a syringe with blue liquid and a needle

Free Download: GLP-1 Medication Comparison One-Pager Compare GLP-1 medications side by side (active ingredients, dosing schedules, and key differences. Get yours free) we'll email it to you instantly. [Download Now]


Blood sugar control. In the AWARD clinical trial program, dulaglutide 1.5 mg reduced A1C by about 1.0 to 1.5 percentage points on average. The higher 4.5 mg dose provided an additional 0.2 to 0.3 point reduction. For context, dropping A1C from 8.5 to 7.0 is clinically meaningful and associated with reduced risk of diabetes complications.

Weight loss. Dulaglutide produces modest weight loss compared to newer GLP-1 medications. At the 1.5 mg dose, average weight loss is around 3 to 5 pounds. At the 4.5 mg dose, some patients lose 8 to 10 pounds. This is less than what semaglutide or tirzepatide typically achieve.

Cardiovascular benefits. The REWIND trial (Gerstein et al., Lancet, 2019) showed that dulaglutide reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 12 percent in people with type 2 diabetes. This trial was notable because it included patients at lower cardiovascular risk than other GLP-1 trials, suggesting broad benefit.

For a side-by-side look at how GLP-1 medications compare, see our .

Side Effects and Practical Considerations

The side effect profile of dulaglutide is similar to other GLP-1 receptor agonists. The most common complaints are gastrointestinal.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Nausea is the most frequently reported side effect, affecting about 12 to 20 percent of users depending on the dose. It tends to be worst during the first two to four weeks and usually improves as your body adjusts. Eating smaller meals, avoiding high-fat foods, and staying hydrated can help.

Diarrhea and constipation affect about 8 to 10 percent of users. Some people experience one or the other. occasionally both at different times.

Injection site reactions like redness or itching are uncommon but possible. Rotating your injection site between your abdomen, thigh, and upper arm can reduce this risk.

Serious but rare risks include pancreatitis and gallbladder problems. Dulaglutide carries a boxed warning about thyroid C-cell tumors seen in rodent studies, though this hasn't been confirmed in humans. People with a personal or family history of medullary thyroid cancer shouldn't use this medication.

For a thorough overview of what to watch for, read our .

If you're weighing your options and want personalized guidance, .

How Dulaglutide Compares to Other GLP-1 Options

Dulaglutide holds a specific position in the GLP-1 field. Here is how it lines up.

Vs. Semaglutide. Semaglutide generally produces greater A1C reduction and significantly more weight loss at comparable doses. Head-to-head trials (SUSTAIN 7) showed semaglutide 1 mg outperformed dulaglutide 1.5 mg for both outcomes. But dulaglutide has broader insurance coverage in some plans and a longer track record.

Vs. Tirzepatide. Tirzepatide, which acts on both GLP-1 and GIP receptors, produces substantially more weight loss and A1C reduction than dulaglutide. For patients whose primary goal is weight management alongside diabetes control, tirzepatide is generally the stronger option.

When dulaglutide makes sense. Dulaglutide remains a solid choice when insurance coverage drives the decision, when the primary goal is blood sugar control rather than weight loss, or when a patient prefers the specific prefilled pen device. It's also well-studied in lower-risk cardiovascular populations, giving providers confidence in prescribing it broadly.

the key point. Dulaglutide is effective for type 2 diabetes management. It isn't the most powerful GLP-1 option for weight loss, but it's proven, convenient, and widely accessible. Your provider can help you decide whether it's the right fit based on your health goals and coverage.

Is dulaglutide FDA-approved for weight loss?

No. Dulaglutide (Trulicity) is FDA-approved for type 2 diabetes management and cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease. While it may cause some weight loss, it isn't approved or marketed as a weight loss medication.

How does the Trulicity pen work?

The Trulicity pen is a prefilled, single-use device with a hidden needle. You access the pen, place it against your skin (abdomen, thigh, or upper arm), and press the injection button. The needle extends automatically, delivers the medication, and retracts. Most users report minimal pain.

Can I switch from dulaglutide to semaglutide or tirzepatide?

Yes, switching between GLP-1 receptor agonists is common. Your provider will typically stop one medication and start the other at the introductory dose, then titrate up. There's usually no washout period needed. Discuss timing and expectations with your provider before making a switch.

Does dulaglutide need to be refrigerated?

Unused pens should be stored in the refrigerator (36 to 46 degrees F). Once you take a pen out, it can be kept at room temperature (up to 86 degrees F) for up to 14 days. Don't freeze dulaglutide and don't use it if it has been frozen.

Next steps for dulaglutide (Trulicity) with your provider

You have the information. Now let a licensed provider help you put it into action. FormBlends makes it simple, answer a few questions and get a personalized recommendation.


  1. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
  2. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
  3. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
  4. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
  5. Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
  6. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

  1. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. Doi:10.1056/NEJMoa1411892
  2. Marso SP, Daniels GH, Tanaka K, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311-322. Doi:10.1056/NEJMoa1603827
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  4. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  5. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  6. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  7. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
  8. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
  9. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2[4] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
  10. Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3[5] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
  11. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4[6] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
  12. Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881

Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.

Last updated: 2026-03-24

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Dulaglutide Trulicity: How It Works and What to Expect
FormBlends guide cover for Dulaglutide Trulicity: How It Works and What to Expect.

Research Snapshot

Research guide
Page type
Research guide
Page metadata
Page updated
2026-09-04
Page metadata
FormBlends official source
Official source
Ozempic official website
Official source
Retatrutide official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-09-04.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Dulaglutide Trulicity: How It Works and What to Expect research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

GLP-1 Weight Loss

Dulaglutide Trulicity For Diabetes

If your doctor has mentioned dulaglutide, you are not alone. This dulaglutide Trulicity guide covers one of the most widely prescribed GLP-1 medications for type 2 diabetes management.

Provider Comparisons

Ozempic vs Trulicity: Semaglutide vs Dulaglutide for Diabetes

Compare Ozempic and Trulicity for diabetes management. Clinical trial data shows semaglutide produces greater weight loss while dulaglutide offers...

Quick Answers

Trulicity Reviews: What 4,200+ Real Patients Say About Dulaglutide in 2026

Real Trulicity patient reviews covering effectiveness, side effects, cost, and injection experience. Plus compounded dulaglutide alternatives.

GLP-1 Weight Loss

Is Trulicity Insulin? No. Here's What It Actually Is and How It Differs

Trulicity is not insulin. It's a GLP-1 receptor agonist (dulaglutide). Here's how it actually works, how it differs from insulin, and when each is used.

GLP-1 Weight Loss

Is Trulicity a Semaglutide? No. Here's Why the Confusion Exists and What Actually Separates Them

No, Trulicity is dulaglutide, not semaglutide. Both are GLP-1 agonists but differ in structure, dosing, efficacy, and side effects. Full comparison.

Patient Experience

Drug Profile: Dulaglutide

Drug Profile: Dulaglutide: patient experience guidance on patient experience, with safety context, decision points, and practical next steps.

GLP-1 Weight Loss

Is Trulicity the Same as Ozempic? The Molecular, Clinical, and Practical Differences That Matter

No. Trulicity (dulaglutide) and Ozempic (semaglutide) are different GLP-1 medications with distinct dosing, efficacy, and side effect profiles.

Conditions & Treatments

Trulicity and Gallstones: The Mechanism Behind the Risk, How to Recognize Symptoms Early, and the Clinical Framework for Deciding When to Switch

Why dulaglutide causes gallstones during weight loss, how to recognize symptoms early, and a clinical framework for deciding when to switch medications.

Conditions & Treatments

Side Effects of Trulicity: Full List, How Often They Happen, and What to Do About Each One

Every documented Trulicity side effect by frequency, what they actually feel like, when to call a provider, and a working protocol to manage the common ones.

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.